NOTCH4 Gene - Notch Receptor 4
Overview
NOTCH4 encodes Notch Receptor 4, a transmembrane protein that functions as a key cell surface receptor in the Notch signaling pathway. Located on chromosome 6q23.3 in humans, the NOTCH4 gene spans approximately 73 kilobases and contains 34 exons. Like other Notch receptors (NOTCH1, NOTCH2, and NOTCH3), NOTCH4 plays a critical role in cell-to-cell communication, regulating cellular differentiation, proliferation, and survival decisions. The Notch signaling pathway is evolutionarily conserved and fundamental to nervous system development and maintenance, making NOTCH4 particularly relevant to understanding neurobiological processes and neurodegenerative conditions.
Function and Biology
...NOTCH4 Gene - Notch Receptor 4
Overview
NOTCH4 encodes Notch Receptor 4, a transmembrane protein that functions as a key cell surface receptor in the Notch signaling pathway. Located on chromosome 6q23.3 in humans, the NOTCH4 gene spans approximately 73 kilobases and contains 34 exons. Like other Notch receptors (NOTCH1, NOTCH2, and NOTCH3), NOTCH4 plays a critical role in cell-to-cell communication, regulating cellular differentiation, proliferation, and survival decisions. The Notch signaling pathway is evolutionarily conserved and fundamental to nervous system development and maintenance, making NOTCH4 particularly relevant to understanding neurobiological processes and neurodegenerative conditions.
Function and Biology
NOTCH4 functions as a large transmembrane receptor (approximately 240 kilodaltons) that mediates juxtacrine signaling—communication between adjacent cells requiring direct physical contact. The protein contains an extracellular region with 29 epidermal growth factor (EGF)-like repeats, a transmembrane domain, and an intracellular region containing ankyrin repeats and a C-terminal transactivation domain. Upon ligand binding by Delta-like (DLL1, DLL3, DLL4) or Jagged (JAG1, JAG2) proteins on neighboring cells, NOTCH4 undergoes sequential proteolytic cleavage. First, the metalloprotease ADAM10 or ADAM17 cleaves the ectodomain, followed by presenilin-dependent gamma-secretase cleavage that releases the Notch intracellular domain (N4ICD). The N4ICD translocates to the nucleus, where it binds CSL proteins (CBF1/RBP-Jκ, Suppressor of Hairless, Lag-1) and co-activators like Mastermind-like proteins to activate target genes including hairy/enhancer of split (HES) and hairy-related (HEY) family transcription factors.
Role in Neurodegeneration
Although NOTCH4 is less frequently implicated in neurodegeneration compared to NOTCH3, emerging evidence suggests its involvement in multiple neurodegenerative processes. NOTCH4 is expressed in adult neural cells, including neurons and vascular endothelial cells within the brain, where it regulates vascular integrity and neuroinflammatory responses. Dysregulated Notch signaling—either through aberrant activation or loss of function—can compromise blood-brain barrier (BBB) maintenance, exacerbate neuroinflammation, and influence neuronal survival decisions. NOTCH4 alterations may contribute to neurodegeneration through compromised vascular stability, reduced endothelial cell-cell adhesion, and increased BBB permeability, allowing peripheral immune infiltration that accelerates neuronal damage. Additionally, NOTCH4 signaling influences microglial activation and cytokine production, potentially modulating neuroinflammatory responses associated with Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
Molecular Mechanisms
NOTCH4-mediated neurodegeneration involves multiple interconnected mechanisms. At the vascular level, NOTCH4 regulates VE-cadherin and claudin expression through HEY family transcription factors, maintaining endothelial adherens junctions essential for BBB integrity. Disrupted NOTCH4 signaling reduces junction protein expression, increasing BBB permeability and permitting neurotoxic protein accumulation. In the immune response, NOTCH4 activation in endothelial cells suppresses inflammatory cytokine production, whereas loss of signaling increases interleukin-6 and tumor necrosis factor-alpha expression. NOTCH4 also regulates neuronal apoptosis through cross-talk with p53 signaling pathways; dysregulation can shift the balance toward pro-apoptotic gene expression. Gamma-secretase inhibitors, which block NOTCH4 cleavage and signaling activation, reveal complex dose-dependent effects on neuroinflammation and neuronal survival, highlighting NOTCH4's nuanced role in disease pathogenesis.
Clinical and Research Significance
NOTCH4 remains an emerging target in neurodegeneration research. Genome-wide association studies have identified NOTCH4 variants associated with cerebral small vessel disease, a vascular contribution to cognitive decline and dementia. Therapeutic modulation of NOTCH4 signaling represents a potential strategy for stabilizing BBB integrity and reducing neuroinflammation in neurodegenerative diseases. Current research focuses on selective NOTCH4 pathway modulation, distinguishing beneficial signaling contexts from harmful ones. Understanding NOTCH4's specific contribution compared to other Notch receptors requires isoform-selective tools and in vivo models, representing active research directions.
- NOTCH3: Disease-causing gene in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
- ADAM10/ADAM17: Proteases mediating NOT